Healthtech
-
Global chocolate maker Hershey taps healthtech startup Elucid to close healthcare gap for Ghana’s cocoa farmers.
For many cocoa farmers in Ghana, a visit to the doctor can mean choosing between medical care and the family’s monthly income. Despite the country’s national insurance system, many rural households remain uninsured or underinsured. Even when clinics are nearby, the upfront cost of treatment often forces farmers to delay care until illnesses become serious.
-
Medpharma secures undisclosed investment from Sahara Impact Ventures.
Ghanaian healthtech startup Medpharma has raised an undisclosed funding round from Sahara Impact Ventures. What problem is MedPharma solving? Founded by Stephen Yaw Asamoah and Richard Appiah Otoo in 2019, MedPharma is digitising healthcare delivery by aggregating providers, pharmacies, and medical facilities into a single connected platform. Its model tackles one of the continent’s most
-
Standard Chartered Women in Tech Incubator backs 5 startups with $50,000 to scale their products.
The Standard Chartered Futuremakers Women in Tech (FWIT) program, an initiative by Standard Chartered Bank, has invested $50,000 in five startups from its 2025 incubator program. These companies span sectors including healthcare and agriculture, and waste management. Implemented by the Ghana Climate Innovation Centre, the program provides business development and financial support to women-led or
-
10 female-led startups selected for Standard Chartered’s Women in Tech Accelerator Program.
Ten women-led startups have been selected to join the fifth cohort of the Standard Chartered Futuremakers Women in Tech (WiT) Accelerator Program, an initiative by Standard Chartered Bank. Launched in 2020 and implemented in partnership with Village Capital and the Ghana Climate Innovation Centre, the incubator equips women-led or owned tech-enabled businesses with the essential
-
Freezelink and Revna Biosciences named on Bloomberg’s Top 25 African Startups to Watch in 2025.
Two Ghanaian startups, Freezelink and Revna Biosciences, have been listed on Bloomberg’s inaugural list of 25 innovative African startups to watch in 2025. Selected from a pool of over 2000 applicants, the top 25 companies consist of some of the continent’s most innovative companies reinventing biotechnology, finance, e-commerce, and eclectic mobility, among other things. Founded
-
Revna Biosciences teams up with AstraZeneca to improve lung cancer testing and treatment in Ghana.
Global pharmaceutical company AstraZeneca has partnered with Ghanaian precision medicine company Revna Biosciences to enhance access to advanced lung cancer testing and targeted therapies. The collaboration focuses on improving diagnosis and treatment for non-small cell lung cancer (NSCLC), the most common form of lung cancer, through Epidermal Growth Factor Receptor (EGFR) biomarker testing. This cutting-edge
-
mPharma and Sproxil selected for the Bill Gates-backed Investing in Innovation Africa program.
mPharma and Sproxil have been selected to join the third cohort of Investing in Innovation Africa (i3), a pan-African initiative that supports healthtech startups improving access to medicines and pharmacy services across the continent. The two companies are among seven growth-stage innovators chosen this year for their impact in transforming pharmaceutical access and healthcare delivery.
-
Aide Chemists selected for the 2025 HealthTech Accelerator Programme.
Aide Chemists, a tech-enabled pharmacy chain, has been selected for the 2025 HealthTech Hub Africa Accelerator Program. This initiative, led by the Novartis Foundation and implemented by Villgro Africa and Jhpiego, supports startups integrating digital health solutions into African public health systems. Founded in 2014 and headquartered in Accra, Aide Chemists operates over 20 pharmacy
-
5 Ghana-based startups make the 2025 Yale Africa Startup Review list of innovators.
Five homegrown startups have earned coveted spots on the 2025 Yale Africa Startup Review (YASR30), an annual list celebrating Africa’s most innovative and high-potential ventures. The annual YASR30 list spotlights startups with the potential to reshape entire industries. A distinguished panel of venture capital judges evaluates submissions based on innovation, scalability, and societal impact. This
-
Yemaachi Biotechnology partners with Roche to establish an Africa-focused cancer genomic and clinical database.
Yemaachi Biotech, a leading genomics research company based in Ghana, has partnered with Roche to launch The African Cancer Atlas (TACA), an initiative to address the significant underrepresentation of African genomic data in global cancer research. This collaboration seeks to establish the world’s most comprehensive cancer genomic database focused on African populations, providing critical insights